Cargando…
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells
Discovery of new actionable targets and functional networks in melanoma is an urgent need as only a fraction of metastatic patients achieves durable clinical benefit by targeted therapy or immunotherapy approaches. Here we show that NFATc2 expression is associated with an EMT-like transcriptional pr...
Autores principales: | Perotti, Valentina, Baldassari, Paola, Molla, Alessandra, Nicolini, Gabriella, Bersani, Ilaria, Grazia, Giulia, Benigni, Fabio, Maurichi, Andrea, Santinami, Mario, Anichini, Andrea, Mortarini, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756060/ https://www.ncbi.nlm.nih.gov/pubmed/30710146 http://dx.doi.org/10.1038/s41388-019-0729-2 |
Ejemplares similares
-
Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation
por: Perotti, V., et al.
Publicado: (2019) -
Synergistic anti-tumor activity and inhibition of angiogenesis by cotargeting of oncogenic and death receptor pathways in human melanoma
por: Grazia, G, et al.
Publicado: (2014) -
Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade
por: Penna, Ilaria, et al.
Publicado: (2015) -
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy
por: Anichini, Andrea, et al.
Publicado: (2022) -
Sema6A and Mical1 control cell growth and survival of BRAF(V600E) human melanoma cells
por: Loria, Rossella, et al.
Publicado: (2014)